The Practice Pearl series is a benefit of membership in The Menopause Society and provides clinical perspectives on important menopause-related issues affecting women during the menopause transition and beyond. Practice Pearls offer an opportunity for continuing education credits and pharmacotherapeutic hours.

Topics covered include:

• Premature menopause
• Risks for cardiovascular disease
• Management of hypoactive sexual desire disorder

…and many more

Practice Pearls Examples

Here is a sneak peek at some of the topics members have access to within each issue of Practice Pearls:

The Menopause Transition: A Critical Stage for Cardiovascular Disease Risk Acceleration in Women

The menopause transition is a critical period for cardiovascular health. During this stage, women experience adverse changes in multiple components that are key for optimal cardiovascular health. Additionally, women struggle to maintain ideal health behaviors, which if adopted collectively, have been shown in observational…

Menopause and Brain Fog: How to Counsel and Treat Midlife Women 
Brain fog, referring to menopause-related subjective cognitive difficulties, is common in midlife women. Longitudinal studies find small but reliable declines in objective memory performance as women transition into perimenopause, and these are not explained by advancing age alone. When memory declines . . .

Sexually Transmitted Infections in Midlife Women
Rates of sexually transmitted infections (STIs) are increasing in all age groups. Although STI incidence decreases with age, midlife women have risk factors that may lead to STI acquisition and underdiagnosis. Clinicians may assume that older women are not sexually active. Although many STIs are asymptomatic, when midlife women do experience vaginal symptoms, they . . . 

Fractional CO2 Laser for Genitourinary Syndrome of Menopause: Evaluating the Evidence
The fractionated CO2 laser has been marketed to women for a variety of gynecologic symptoms and conditions, including the genitourinary syndrome of menopause (GSM). The evidence has been limited, precluding conclusions regarding the efficacy and safety of the therapy. However, data from randomized, controlled trials evaluating this technology for GSM are now available. This Practice Pearl addresses the latest data concerning…

Primary Ovarian Insufficiency: A Toolkit for the Busy Clinician
Primary ovarian insufficiency (sometimes known as premature ovarian insufficiency) is a result of loss of ovarian follicular activity before the age of 40 years. It is an endocrine deficiency state in women, characterized by premature estrogen deprivation. In the absence of estrogen replacement, women experience…

Reproductive Risk Factors for Cardiovascular Disease in Women
Cardiovascular disease (CVD) remains the leading cause of death for women. Adverse pregnancy outcomes, including hypertensive disorders of pregnancy, gestational diabetes mellitus, preterm delivery, and low birth weight—affecting up to 30% of pregnant women—increase the risk of CVD. Early menarche and polycystic…

Evaluation and Treatment of Vulvovaginal Itching in Postmenopausal Women

Vulvovaginal itching, a commonly reported symptom in postmenopausal women, may be because of the genitourinary syndrome of menopause but has a broad differential including dermatologic, infectious, and autoimmune causes. Comprehensive evaluation is important to avoid inappropriate treatments…

Testosterone Use for Hypoactive Sexual Desire Disorder in Postmenopausal Women

Testosterone is an important evidence-based therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal women. Clinical practice guidelines based on the most comprehensive meta-analysis of benefits and risks of testosterone therapy to date state that the sole evidence-based indication for testosterone…

Clinical Considerations for Menopause and Associated Symptoms in Women With HIV

Worldwide, more women with HIV are aging and entering menopause. Although a limited number of evidenced-based care recommendations are published, formal guidelines for the management of menopause in women with HIV are not available. Many women with HIV receive primary care from HIV infectious…

Aspirin for Primary Prevention of Cardiovascular Disease in Women

Aspirin use for primary prevention of cardiovascular disease is controversial. Low-dose aspirin may be considered for primary prevention in women on an individualized basis for those aged 40 to 59 years with a 10-year cardiovascular risk of 10% or more and without increased bleeding risk. Low-dose aspirin…

…and many more